Cargando…
Improving Access to Cancer Treatments: The Role of Biosimilars
Biologics play a key role in cancer treatment and are principal components of many therapeutic regimens. However, they require complex manufacturing processes, resulting in high cost and occasional shortages in supply. The cost of biologics limits accessibility of cancer treatment for many patients....
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646904/ https://www.ncbi.nlm.nih.gov/pubmed/29094099 http://dx.doi.org/10.1200/JGO.2016.008607 |